Zhangzhou Pientzehuang Pharmaceutical Ltd (600436.SS)
19 Jan 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|54||2014||Chairman of the Board|
|52||2007||Chief Financial Officer, Director|
|49||2017||Deputy General Manager, Secretary of the Board, Director|
|47||2006||Deputy General Manager|
|46||2014||Deputy General Manager|
- BRIEF-Zhangzhou Pientzehuang Pharmaceutical Sees 2017 Net Profit Up 40-60 Percent Y/Y
- BRIEF-Zhangzhou Pientzehuang Pharmaceutical passes review of high-tech enterprise recognition
- BRIEF-Zhangzhou Pientzehuang Pharma's 9-month net profit up 40.3 pct y/y
- BRIEF-Zhangzhou Pientzehuang Pharmaceutical elects Liu Jianshun as chairman
- BRIEF-Zhangzhou Pientzehuang Pharmaceutical's H1 net profit up 41.8 pct y/y